TSCA

May 20, 2022
Congressional Committees Hold Additional Hearings on EPA’s FY 2023 Budget Request
May 18, 2022
Proposed Rule Concerning CBI Claims under TSCA Addresses EPA Review of Confidentiality Claims and Related Revisions to Other TSCA Rules
May 6, 2022
EPA Proposes TSCA Reporting and Recordkeeping Requirements for Asbestos
May 2, 2022
House Subcommittee Holds Hearing on FY 2023 Budget Request for EPA
April 22, 2022
EPA Holds Meeting on TSCA New Chemicals Collaborative Research Program
April 12, 2022
Senate Committee Hearing on Proposed FY 2023 EPA Budget Includes Discussion of TSCA and FIFRA Issues
April 7, 2022
EPA Holds Webinar on New Chemical Risk Management Actions for Biofuels
April 7, 2022
EPA Will Propose to Ban Ongoing Uses of Asbestos
March 17, 2022
EPA Actions to Address PFAS in Commerce Include TSCA Compliance Notification Letter on PFAS in HDPE Containers
March 14, 2022
EPA Posts Draft Document on “Modernizing the Process and Bringing Innovative Science to Evaluate New Chemicals Under TSCA”
March 8, 2022
EPA Publishes Final Scope of D4 Risk Evaluation, Seeks Comment on Draft Revision to PV29 Risk Determination
March 7, 2022
EPA Will Extend Compliance Dates for Articles Containing PIP (3:1)
March 1, 2022
EPA Holds Webinar on TSCA Requirements and PMN Process for Biofuels
January 24, 2022
EPA Requests Comment on Draft TSCA Screening Methodology to Evaluate Chemical Exposures and Risks to Fenceline Communities
January 3, 2022
Forecast for U.S. Federal and International Chemical Regulatory Policy 2022
December 30, 2021
EPA Publishes Draft Scope of the Risk Evaluation for Asbestos Part 2: Supplemental Evaluation Including Legacy Uses and Associated Disposals of Asbestos
December 29, 2021
Draft Revision to Risk Determination for HBCD Retains Finding of Unreasonable Risk of Injury
December 21, 2021
EPA Intends Draft TSCA Systematic Review Protocol to Strengthen Science Used in Chemical Risk Evaluations
December 9, 2021
EPA Publishes Updated NAMs Work Plan
December 8, 2021
House Subcommittees Hold Hearing on PFAS R&D
October 28, 2021
House Committee Holds Hearing on “TSCA and Public Health: Fulfilling the Promise of the Lautenberg Act”
October 25, 2021
EPA Proposes Further Extension of Compliance Dates for PIP (3:1)-Containing Articles
October 21, 2021
Senate Committee Holds Hearing on “Evaluating the Federal Response to the Persistence and Impacts of PFAS Chemicals on our Environment”
October 19, 2021
Biden Administration Announces Multi-Agency Plan to Confront PFAS Pollution; EPA Releases Strategic Roadmap
September 3, 2021
EPA Plans New Rulemaking for PBTs, Extends Compliance Dates for PIP (3:1) Rule
September 3, 2021
EPA Publishes Final Risk Evaluation Scope Documents for DIDP and DINP
August 5, 2021
EPA Will Delay 1,4-Dioxane Risk Management until Nearing Completion of Reconsideration of Risk Evaluation
July 29, 2021
EPA Holds Public Webinar on Development of Proposed TSCA Data Reporting Rule
July 1, 2021
ELI Concludes Another Successful Annual TSCA Conference
June 29, 2021
Manufacturers and Importers of 20 High-Priority Chemicals and 30 Organohalogen Flame Retardants Must Submit Data to EPA
June 11, 2021
EPA Announces Three PFAS Actions, Including Proposed TSCA Section 8(a) Reporting Rule
May 25, 2021
EPA Poised to Propose TSCA Section 8(a) Reporting Rule on PFAS Chemicals
May 12, 2021
Senate Committee Holds Hearing on Nominee for EPA Assistant Administrator for Chemical Safety and Pollution Prevention
March 29, 2021
EPA Announces Updates to TSCA New Chemicals Program
March 12, 2021
EPA Receives Petition Seeking RCRA and TSCA Regulatory Action for Phosphogypsum and Process Wastewater
March 11, 2021
House Committee Holds Hearing on “Restoring the Vital Mission of EPA”
February 1, 2021
EPA Issues TSCA Section 4 Test Orders for Nine Chemicals Undergoing Risk Evaluation
January 25, 2021
EPA Completes Final Risk Evaluation for PV29, Finding Unreasonable Risks to Workers and ONUs from Ten Uses
January 20, 2021
EPA and OSHA Sign MOU Regarding EPA’s Review of New Chemicals under TSCA
January 13, 2021
Final Risk Evaluation for 1,4-Dioxane Finds Unreasonable Risk to Workers for Certain Uses
January 4, 2021
EPA Publishes Final Risk Evaluation for Asbestos, Part 1:  Chrysotile Asbestos
December 30, 2020
EPA Intends Proposed Rule to Increase Flexibility and Reduce Burdens under TSCA Fees Program
December 29, 2020
EPA Releases Final Chemical Risk Evaluation for NMP
December 23, 2020
EPA Releases Final TSCA Section 6(h) Rules for Five PBT Chemicals
December 17, 2020
Final Risk Evaluation for Perchloroethylene Finds 59 Conditions of Use Pose Unreasonable Risks to Workers, ONUs, Consumers, and Bystanders
December 14, 2020
EPA Publishes Draft Compliance Guide Addressing Surface Coatings under PFAS SNUR
December 10, 2020
Manufacturer and Importer Liability under the TSCA Fees Rule for EPA-Initiated Risk Evaluations: An Opaque and Evolving Story
December 1, 2020
EPA Releases Draft Scope Documents for Risk Evaluations of DIDP and DINP for Public Comment
November 24, 2020
EPA Evaluates 54 Conditions of Use for TCE, Finding That 52 Present an Unreasonable Risk
November 4, 2020
Final Risk Evaluation for Carbon Tetrachloride Finds Unreasonable Risks to Workers and Occupational Non-Users
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2022 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.